Wellbutrin Tablet, Film Coated
Product Images NDC 0173-0135

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Wellbutrin (NDC 0173-0135). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glaxosmithkline Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

00173 0135 55 Splimage30 E718f397

Wellbutrin SR 150 mg oral film-coated tablet, round and purple in color, with imprint 'WELLBUTRIN SR 150' in black on one side and plain on the other side. Manufactured by GlaxoSmithKline LLC.*

FDA Label Image

00173 0722 00 Splimage30 F918fcf7

Wellbutrin SR 200 mg film-coated oral tablet shown in front and back views. The round, pink tablet has the imprint 'WELLBUTRIN SR 200' on one side in black lettering, with the other side being plain. Manufactured by GlaxoSmithKline LLC.*

FDA Label Image

00173 0947 55 Splimage30 B818dc56

Blue, round, film-coated tablet of WELLBUTRIN SR 100 mg. One side is imprinted with "WELLBUTRIN SR 100" in black text. The other side of the tablet is blank. The scale indicates the tablet is about 10 mm in diameter.*

FDA Label Image

Buproprion Hydrochloride Chemical Structure (Wellbutrinsr Spl Graphic 01)

Chemical structure diagram showing the molecular formula of bupropion hydrochloride. The image includes a benzene ring with associated chemical groups and a hydrochloride component, representing the active ingredient in WELLBUTRIN SR tablets.*

FDA Label Image

Wellbutrin Sr 100 mg 60 Count Label (Wellbutrinsr Spl Graphic 02)

Label for Wellbutrin SR 100 mg sustained-release film-coated tablets by GlaxoSmithKline LLC. The label indicates strength as 100 mg bupropion hydrochloride per tablet, oral route, with 60 tablets in the package. It includes a federal law reminder regarding dispensing with the medication guide and storage instructions.*

FDA Label Image

Wellbutrin Sr 150 mg 60 Count Label (Wellbutrinsr Spl Graphic 03)

Label for Wellbutrin SR 150 mg sustained-release tablets containing bupropion hydrochloride by GlaxoSmithKline LLC. The label specifies twice-a-day dosing after initial titration and includes a warning to not use with other bupropion HCL medicines. The package contains 60 film-coated tablets and notes storage conditions at controlled room temperature.*

FDA Label Image

Wellbutrin Sr 200 mg 60 Count Label (Wellbutrinsr Spl Graphic 04)

Label for Wellbutrin SR 200 mg sustained-release tablets containing bupropion hydrochloride. The bottle label indicates a twice-a-day dosing schedule after initial titration and holds 60 film-coated tablets. Manufactured by GlaxoSmithKline LLC, the label includes a federal law warning to dispense with the Medication Guide and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.